Case report: Unexpected chest lesionsA patient's one "additional" concern turns out to be a startling and interesting case. Efficacy and safety of deucravacitinib in the treatment of plaque psoriasisStudy explores whether this treatment can be an effective and well-tolerated once-daily option. A promising app for assessing skin cancer risk While improvements are still needed, a new app holds promise for empowering patients to self-assess lesions before consulting a healthcare professional. Case report: Allergy or virus-related rash? It is interesting to learn how patients connect (or fail to connect) life events to medical problems. Merck, Moderna detail potential skin cancer vaccine progress The drugmakers said a potential skin cancer vaccine they are developing using the same tech behind COVID-19 shots fared well in a small study. Case report: Cure for foot fungus? A patient claims to have found a cure for his persistent foot fungus, but Dr. Robert Dickson has doubts. New psoriasis drug approved by Health Canada Health Canada has approved SOTYKTU (deucravacitinib tablets), a new psoriasis medication. It’s the first TYK2 inhibitor to be approved in Canada. QUIZ: Test your knowledge of acne vulgaris How much do you know about treatment of acne? What’s a doctor to do? Various guidelines for skin cancer follow-up are inconsistent Review of guidelines is ‘a call to action.’ Case report: a wart problem As Dr. Robert Dickson notes, warts are a frequently frustrating problem for patients and a challenge for physicians. First Previous 20 21 22 23 24 Next Last
